Trial intelligence / Profile preview

Phase II ADV-TK plus ganciclovir study in recurrent late-stage head and neck cancer

ChiCTR-ONRC-11001232Phase 2Completed

Sponsor

Shenzhen Tiandakang Gene Engineering

Start

Dec 2007

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules

Countries

1